Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Why do our patients get chemotherapy until the end of life?

Literature DB >> 21917739

Why do our patients get chemotherapy until the end of life?

S Braga¹.

Abstract

Entities: Species

Mesh：

Substances：
Antineoplastic Agents

Year: 2011 PMID： 21917739 DOI： 10.1093/annonc/mdr416

Source DB: PubMed Journal: Ann Oncol ISSN： 0923-7534 Impact factor: 32.976

Keyword Cloud
Cited

× No keyword cloud information.

21 in total

Review 1. Practical guidelines for developing new palliative care services: resource management.

Authors: T J Smith; P J Coyne; J B Cassel
Journal: Ann Oncol Date: 2012-04 Impact factor: 32.976

2. Commentary: "the Lake Wobegon effect, a natural human tendency to overestimate one's capabilities" (Wikipedia).

Authors: Thomas J Smith
Journal: Milbank Q Date: 2013-12 Impact factor: 4.911

3. End-of-life chemotherapy is associated with poor survival and aggressive care in patients with small cell lung cancer.

Authors: Yingming Zhu; Ke Tang; Fen Zhao; Yuanwei Zang; Xiaodong Wang; Zhenxiang Li; Xindong Sun; Jinming Yu
Journal: J Cancer Res Clin Oncol Date: 2018-05-29 Impact factor: 4.553

4. Treatment of cancer patients in their last month of life: aimless chemotherapy.

Authors: Tarek Assi; Elie El Rassy; Samer Tabchi; Toni Ibrahim; Tania Moussa; Ralph Chebib; Fadi El Karak; Fadi Farhat; Georges Chahine; Fadi Nasr; Marwan Ghosn; Joseph Kattan
Journal: Support Care Cancer Date: 2015-09-21 Impact factor: 3.603

5. Engaging a Community Chaplaincy Resource for Interprofessional Health Care Provider Training in Facilitating Family Decision Making for Children at End-of-Life.

Authors: Randal K Wada; Lorrie Wong; Anke Flohr; David Kurahara; Robin Arndt; Melodee J Deutsch; Dana Ing; Karol Richardson; Alexander Munro; Lori Kaneshige; Mary Mullis; Mychal Hatae; Cheryl L Albright
Journal: Hawaii J Med Public Health Date: 2019-06

6. Chemotherapy Use, Performance Status, and Quality of Life at the End of Life.

Authors: Holly G Prigerson; Yuhua Bao; Manish A Shah; M Elizabeth Paulk; Thomas W LeBlanc; Bryan J Schneider; Melissa M Garrido; M Carrington Reid; David A Berlin; Kerin B Adelson; Alfred I Neugut; Paul K Maciejewski
Journal: JAMA Oncol Date: 2015-09 Impact factor: 31.777

Why do our patients get chemotherapy until the end of life?

Review 1. Practical guidelines for developing new palliative care services: resource management.

2. Commentary: "the Lake Wobegon effect, a natural human tendency to overestimate one's capabilities" (Wikipedia).

3. End-of-life chemotherapy is associated with poor survival and aggressive care in patients with small cell lung cancer.

4. Treatment of cancer patients in their last month of life: aimless chemotherapy.

5. Engaging a Community Chaplaincy Resource for Interprofessional Health Care Provider Training in Facilitating Family Decision Making for Children at End-of-Life.

6. Chemotherapy Use, Performance Status, and Quality of Life at the End of Life.

7. What determines the timing of discussions on forgoing anticancer treatment? A national survey of medical oncologists.

8. To Treat or Not to Treat Metastatic Cancer Patients with Poor Performance Status: a Prospective Experience.

9. Prognostic Significance of Patient-Reported Outcomes in Cancer.

10. Aggressiveness of cancer treatment in patients hospitalized in a supportive care unit.